Login / Signup

Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes.

Han Na JangYe Seul YangSeong Ok LeeTae Jung OhBo Kyung KooHye Seung Jung
Published in: Endocrinology and metabolism (Seoul, Korea) (2020)
We observed a significant glucose-lowering effect by replacing basal insulin with IDegAsp, especially in patients with a lower m-FPG than p-FPG.
Keyphrases
  • glycemic control
  • type diabetes
  • blood glucose
  • weight loss
  • physical activity
  • skeletal muscle